Cross-presentation in mouse and human dendritic cells
E Segura, S Amigorena - Advances in immunology, 2015 - Elsevier
Cross-presentation designates the presentation of exogenous antigens on major
histocompatibility complex class I molecules and is essential for the initiation of cytotoxic …
histocompatibility complex class I molecules and is essential for the initiation of cytotoxic …
Lipid bodies containing oxidatively truncated lipids block antigen cross-presentation by dendritic cells in cancer
Cross-presentation is a critical function of dendritic cells (DCs) required for induction of
antitumor immune responses and success of cancer immunotherapy. It is established that …
antitumor immune responses and success of cancer immunotherapy. It is established that …
M2 macrophage-derived extracellular vesicles facilitate CD8+ T cell exhaustion in hepatocellular carcinoma via the miR-21-5p/YOD1/YAP/β-catenin pathway
J Pu, Z Xu, J Nian, Q Fang, M Yang, Y Huang, W Li… - Cell death …, 2021 - nature.com
Hepatocellular carcinoma (HCC) is a common malignancy. CD8+ T cell-mediated immune
response is critical for the inhibition of HCC progression. M2 macrophages participate in …
response is critical for the inhibition of HCC progression. M2 macrophages participate in …
Genetic disruption of mammalian endoplasmic reticulum‐associated protein degradation: Human phenotypes and animal and cellular disease models
Endoplasmic reticulum‐associated protein degradation (ERAD) is a stringent quality control
mechanism through which misfolded, unassembled and some native proteins are targeted …
mechanism through which misfolded, unassembled and some native proteins are targeted …
[HTML][HTML] Small molecule enhancers of endosome-to-cytosol import augment anti-tumor immunity
Cross-presentation of antigens by dendritic cells (DCs) is critical for initiation of anti-tumor
immune responses. Yet, key steps involved in trafficking of antigens taken up by DCs remain …
immune responses. Yet, key steps involved in trafficking of antigens taken up by DCs remain …
Deubiquitinase YOD1 potentiates YAP/TAZ activities through enhancing ITCH stability
Y Kim, W Kim, Y Song, JR Kim, K Cho… - Proceedings of the …, 2017 - National Acad Sciences
Hippo signaling controls the expression of genes regulating cell proliferation and survival
and organ size. The regulation of core components in the Hippo pathway by …
and organ size. The regulation of core components in the Hippo pathway by …
YOD1 serves as a potential prognostic biomarker for pancreatic cancer
Z Zhang, W Zhao, Y Li, Y Li, H Cheng, L Zheng… - Cancer Cell …, 2022 - Springer
Background Ubiquitination is a basic post-translational modification of intracellular proteins
and can be reversed enzymatically by DUBs (deubiquitinating enzymes). More than 90 …
and can be reversed enzymatically by DUBs (deubiquitinating enzymes). More than 90 …
miR-221/222 induce instability of p53 By downregulating deubiquitinase YOD1 in acute myeloid leukemia
HZ Pei, Z Peng, X Zhuang, X Wang, B Lu, Y Guo… - Cell Death …, 2023 - nature.com
Acute myeloid leukemia (AML) is a hematological malignancy characterized by the impaired
differentiation and uncontrolled proliferation of myeloid blasts. Tumor suppressor p53 is …
differentiation and uncontrolled proliferation of myeloid blasts. Tumor suppressor p53 is …
[HTML][HTML] Blockade of deubiquitinase YOD1 degrades oncogenic PML/RARα and eradicates acute promyelocytic leukemia cells
X Shao, Y Chen, W Wang, W Du, X Zhang… - … Pharmaceutica Sinica B, 2022 - Elsevier
In most acute promyelocytic leukemia (APL) cells, promyelocytic leukemia (PML) fuses to
retinoic acid receptor α (RARα) due to chromosomal translocation, thus generating …
retinoic acid receptor α (RARα) due to chromosomal translocation, thus generating …
Rab8a restores diverse innate functions in CD11c+CD11b+ dendritic cells from aged mice
Age-related alterations of the immune system compromise the host's ability to respond to
pathogens, but how immune aging is regulated is still poorly understood. Here, we identify …
pathogens, but how immune aging is regulated is still poorly understood. Here, we identify …